Macrogenics Inc (NASDAQ: MGNX) kicked off on Tuesday, up 6.29% from the previous trading day, before settling in for the closing price of $1.43. Over the past 52 weeks, MGNX has traded in a range of $0.99-$4.39.
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.47%. While this was happening, its average annual earnings per share was recorded -74.94%. With a float of $58.06 million, this company’s outstanding shares have now reached $63.21 million.
Macrogenics Inc (MGNX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 8.14%, while institutional ownership is 71.98%. The most recent insider transaction that took place on Aug 19 ’25, was worth 76,760. In this transaction Director of this company bought 50,500 shares at a rate of $1.52, taking the stock ownership to the 61,500 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 49,500 for $1.49, making the entire transaction worth $73,755. This insider now owns 111,000 shares in total.
Macrogenics Inc (MGNX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.9 earnings per share (EPS), higher than consensus estimate (set at 0.6) by 0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -74.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -23.32% during the next five years compared to 19.47% growth over the previous five years of trading.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Take a look at Macrogenics Inc’s (MGNX) current performance indicators. Last quarter, stock had a quick ratio of 5.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.86 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Looking closely at Macrogenics Inc (NASDAQ: MGNX), its last 5-days average volume was 0.53 million, which is a drop from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 30.99%.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 32.37%, which indicates a significant decrease from 35.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1113 in the past 14 days, which was lower than the 0.1259 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6901, while its 200-day Moving Average is $1.7467. However, in the short run, Macrogenics Inc’s stock first resistance to watch stands at $1.5667. Second resistance stands at $1.6133. The third major resistance level sits at $1.6867. If the price goes on to break the first support level at $1.4467, it is likely to go to the next support level at $1.3733. Should the price break the second support level, the third support level stands at $1.3267.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
The company with the Market Capitalisation of 96.07 million has total of 63,206K Shares Outstanding. Its annual sales at the moment are 149,960 K in contrast with the sum of -66,970 K annual income. Company’s last quarter sales were recorded 22,240 K and last quarter income was -36,250 K.
